MC

475

+0.98%↑

SAF

291.8

-0.58%↓

SANES

8.251

+0.6%↑

BBVA

16.52

+1.19%↑

BNP

83.88

+0.04%↑

MC

475

+0.98%↑

SAF

291.8

-0.58%↓

SANES

8.251

+0.6%↑

BBVA

16.52

+1.19%↑

BNP

83.88

+0.04%↑

MC

475

+0.98%↑

SAF

291.8

-0.58%↓

SANES

8.251

+0.6%↑

BBVA

16.52

+1.19%↑

BNP

83.88

+0.04%↑

MC

475

+0.98%↑

SAF

291.8

-0.58%↓

SANES

8.251

+0.6%↑

BBVA

16.52

+1.19%↑

BNP

83.88

+0.04%↑

MC

475

+0.98%↑

SAF

291.8

-0.58%↓

SANES

8.251

+0.6%↑

BBVA

16.52

+1.19%↑

BNP

83.88

+0.04%↑

Search

Sartorius Stedim Biotech.

Затворен

СекторФинансови

177.4 0.08

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

177.2

Максимум

177.5

Ключови измерители

By Trading Economics

Приходи

-23M

93M

Продажби

400K

745M

P/E

Средно за сектора

73.609

26.512

EPS

1.18

Дивидентна доходност

0.41

Марж на печалбата

12.43

Служители

10,030

EBITDA

-55M

201M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+24.83% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.41%

3.75%

Следващи печалби

16.10.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-3.3B

17B

Предишно отваряне

177.32

Предишно затваряне

177.4

Настроения в новините

By Acuity

27%

73%

88 / 535 Класиране в Finance

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

Sartorius Stedim Biotech. Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

15.08.2025 г., 16:11 ч. UTC

Значими двигатели на пазара

Health Insurers Climb as Berkshire Hathaway Takes UnitedHealth Stake

15.08.2025 г., 22:22 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

15.08.2025 г., 22:22 ч. UTC

Пазарно говорене

Target Is Falling Behind Its Peers -- Market Talk

15.08.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

15.08.2025 г., 20:33 ч. UTC

Пазарно говорене

U.S. Treasury Yields Close the Week Little Changed -- Market Talk

15.08.2025 г., 20:25 ч. UTC

Печалби
Придобивния, сливания и поглъщания

This Meatpacker Stock Is a Quality Buy at a Discount Price -- Barrons.com

15.08.2025 г., 20:24 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Nucor Stock Gets a Boost From Buffett. Berkshire's Last Steel Buy Didn't Go So Well. -- Barrons.com

15.08.2025 г., 20:18 ч. UTC

Печалби

Deere's Earnings Brought a Surprise. It Wasn't the Usual Kind. -- Barrons.com

15.08.2025 г., 19:14 ч. UTC

Пазарно говорене

U.S. Natural Gas Settles Higher, But Down on Week -- Market Talk

15.08.2025 г., 19:12 ч. UTC

Пазарно говорене

Oil Futures Settle Lower Ahead of U.S.-Russia Summit -- Market Talk

15.08.2025 г., 18:32 ч. UTC

Пазарно говорене

Coffee Futures Surge on New Brazilian Frost -- Market Talk

15.08.2025 г., 17:33 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Increases By 1 to 412 -- Market Talk

15.08.2025 г., 17:23 ч. UTC

Пазарно говорене
Печалби

Deere's Earnings Appear to Be Troughing -- Market Talk

15.08.2025 г., 16:27 ч. UTC

Печалби

Tariffs Have Rocked e.l.f. Beauty Shares. Why the Fundamentals Still Look Alluring. -- Barrons.com

15.08.2025 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

15.08.2025 г., 16:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

15.08.2025 г., 16:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

15.08.2025 г., 16:05 ч. UTC

Придобивния, сливания и поглъщания

Intel's Move Toward Nationalization Won't Work -- at Least for the Long Haul -- Heard on the Street -- WSJ

15.08.2025 г., 15:52 ч. UTC

Придобивния, сливания и поглъщания

What Applied Materials' Poor Outlook Means for Chip Stocks -- Barrons.com

15.08.2025 г., 15:36 ч. UTC

Пазарно говорене

Base Metal Prices Mixed; Copper Gains as Focus Shifts to Fundamentals -- Market Talk

15.08.2025 г., 15:29 ч. UTC

Печалби

Deere's Earnings Brought a Surprise. It Wasn't the Usual Kind. -- Barrons.com

15.08.2025 г., 15:29 ч. UTC

Придобивния, сливания и поглъщания

Nucor Stock Gets a Boost From Buffett. Berkshire's Last Steel Buy Didn't Go So Well. -- Barrons.com

15.08.2025 г., 15:28 ч. UTC

Печалби

JD.com Stock Rises After Earnings Beat. Why Investors Are Relieved. -- Barrons.com

15.08.2025 г., 15:24 ч. UTC

Пазарно говорене

Gold Futures Tick Higher But Remain Broadly Rangebound -- Market Talk

15.08.2025 г., 15:08 ч. UTC

Пазарно говорене

Applied Materials Is Losing Share in Chips Business -- Market Talk

15.08.2025 г., 14:38 ч. UTC

Придобивния, сливания и поглъщания

African Rainbow Minerals to Own 19.9% of Surge Copper Shares

15.08.2025 г., 14:37 ч. UTC

Придобивния, сливания и поглъщания

African Rainbow Minerals to Buy 25.8 Million Surge Copper Shares for C$4.51M

15.08.2025 г., 14:37 ч. UTC

Придобивния, сливания и поглъщания

African Rainbow Minerals to Buy 25.8 Million Surge Copper Shares at C$0.175 Each

15.08.2025 г., 14:36 ч. UTC

Придобивния, сливания и поглъщания

African Rainbow Minerals to Acquire Shares of Surge Copper Corp.

15.08.2025 г., 14:33 ч. UTC

Придобивния, сливания и поглъщания

A Trump Intel Stake Could Make National Security the New 'Too Big to Fail' -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Sartorius Stedim Biotech. Прогноза

Ценова цел

By TipRanks

24.83% нагоре

12-месечна прогноза

Среден 221.44 EUR  24.83%

Висок 240 EUR

Нисък 174 EUR

Според 9 анализатори от Wall Street, предложили 12-месечна ценова цел за Sartorius Stedim Biotech. през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

9 ratings

6

Купи

3

Задържане

0

Продай

Техническа оценка

By Trading Central

202.7 / 211.7Подкрепа & съпротива

Краткосрочен план

Bullish Evidence

Средносрочен план

Strong Bullish Evidence

Дългосрочен план

Strong Bullish Evidence

Настроение

By Acuity

88 / 535 Класиране в Финансови

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.